Klaus Lechner spends much of his time researching Internal medicine, Immunology, Gastroenterology, Myeloid leukemia and Surgery. His work on Internal medicine is being expanded to include thematically relevant topics such as Endocrinology. Much of his study explores Immunology relationship to Cell culture.
His work deals with themes such as Protein S, Protein S deficiency, Cytarabine, Neutropenia and Protein C deficiency, which intersect with Gastroenterology. His Myeloid leukemia research incorporates themes from Gene expression, Oncology, Real-time polymerase chain reaction, White blood cell and Leukemia. When carried out as part of a general Surgery research project, his work on Thrombosis, Retrospective cohort study and Randomized controlled trial is frequently linked to work in Multicenter trial, therefore connecting diverse disciplines of study.
His scientific interests lie mostly in Internal medicine, Immunology, Gastroenterology, Bone marrow and Surgery. Internal medicine is closely attributed to Endocrinology in his research. His Immunology research is multidisciplinary, incorporating perspectives in Progenitor cell, Molecular biology and Haematopoiesis.
His Gastroenterology course of study focuses on Thrombosis and Risk factor. In the subject of general Surgery, his work in Transplantation, Cyclophosphamide and Complication is often linked to In patient, thereby combining diverse domains of study. Klaus Lechner interconnects Myeloid and Oncology in the investigation of issues within Leukemia.
His primary areas of study are Internal medicine, Immunology, Gastroenterology, Surgery and Bone marrow. Klaus Lechner works mostly in the field of Internal medicine, limiting it down to topics relating to Oncology and, in certain cases, Proportional hazards model, as a part of the same area of interest. Klaus Lechner combines subjects such as Dermatology and Progenitor cell, Stem cell factor with his study of Immunology.
His Gastroenterology research is multidisciplinary, relying on both Coagulopathy, Complication, Chemotherapy and Minimal residual disease. His work is dedicated to discovering how Surgery, Splenectomy are connected with Autoimmune thrombocytopenia, Prednisolone and Incidence and other disciplines. His biological study spans a wide range of topics, including Haematopoiesis and Tryptase.
Klaus Lechner focuses on Internal medicine, Surgery, Gastroenterology, Immunology and Myeloid leukemia. His Internal medicine research integrates issues from Pediatrics, Tryptase and Cytogenetics. His work carried out in the field of Surgery brings together such families of science as Essential thrombocythemia, Polycythemia vera and Splenectomy.
His Gastroenterology study incorporates themes from Nitrogen mustard, Complication, Factor V and Coagulopathy. His study in Immunology is interdisciplinary in nature, drawing from both Dermatology and Cell. His Myeloid leukemia research includes elements of Chronic myelogenous leukemia, Leukemia and CD117.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
HIGH PLASMA LEVELS OF FACTOR VIII AND THE RISK OF RECURRENT VENOUS THROMBOEMBOLISM
Paul A. Kyrle;Erich Minar;Mirko Hirschl;Christine Bialonczyk.
The New England Journal of Medicine (2000)
Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture.
Peter Valent;Eva Spanblochl;Wolfgang R. Sperr;Christian Sillaber.
Blood (1992)
MDR1 Gene Expression and Treatment Outcome in Acute Myeloid Leukemia
Robert Pirker;Josef Wallner;Klaus Geissler;Werner Linkesch.
Journal of the National Cancer Institute (1991)
A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of Filgrastim in Remission Induction and Consolidation Therapy for Adults With De Novo Acute Myeloid Leukemia
Gerhard Heil;Dieter Hoelzer;Miguel A. Sanz;Klaus Lechner.
Blood (1997)
Hyperhomocysteinemia Is a Risk Factor of Recurrent Venous Thromboembolism
S. Eichinger;A. Stümpflen;M. Hirschl;C. Bialonczyk.
Thrombosis and Haemostasis (1998)
Mast cell typing: demonstration of a distinct hematopoietic cell type and evidence for immunophenotypic relationship to mononuclear phagocytes.
P Valent;LK Ashman;W Hinterberger;F Eckersberger.
Blood (1989)
1,25-Dihydroxyvitamin D3 inhibits dendritic cell differentiation and maturation in vitro
Andrea Berer;Johannes Stöckl;Otto Majdic;Thomas Wagner.
Experimental Hematology (2000)
Interleukin-3 is a differentiation factor for human basophils.
P Valent;G Schmidt;J Besemer;P Mayer.
Blood (1989)
Diagnostic value of immunostaining for tryptase in patients with mastocytosis.
Hans-Peter Horny;Christian Sillaber;David Menke;Edwin Kaiserling.
The American Journal of Surgical Pathology (1998)
The risk of recurrent venous thromboembolism in patients with and without factor V Leiden
S Eichinger;I Pabinger;A Stümpflen;M Hirschl.
Thrombosis and Haemostasis (1997)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Medical University of Vienna
Medical University of Vienna
University of Vienna
Medical University of Vienna
Medical University of Vienna
Medical University of Vienna
University of Vienna
University of Vienna
Medical University of Vienna
European Medicines Agency
Stanford University
Tatung University
Harvard University
University of Valencia
University of Canberra
The Ohio State University
Tokyo University of Agriculture
University of Pisa
Laboratoire Interuniversitaire des Systèmes Atmosphériques
Royal Netherlands Meteorological Institute
University of Minnesota
University of Wisconsin–Madison
Stanford University
University of Cambridge
Michigan State University
University of Wisconsin–Madison